GLUC OTC
Glucose Health, Inc.
1W: +12.1%
1M: -0.1%
3M: -0.1%
YTD: +109.0%
1Y: +798.8%
3Y: +83.7%
5Y: -84.3%
$0.45
+0.10 (+26.87%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$384K
-28.2% ▼
5Y CAGR: +5.7%
Gross Profit
$76K
-65.0% ▼
5Y CAGR: +7.5%
Operating Income
-$307K
+27.3% ▲
Net Income
-$316K
+25.1% ▲
EPS (Diluted)
$-0.03
+13.9% ▲
EBITDA
-$305K
+27.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $481K | $954K | $1M | $535K | $384K |
| YoY Growth | +65.1% | +98.4% | +12.5% | -50.1% | -28.2% |
| Cost of Revenue | $307K | $544K | $616K | $319K | $309K |
| Gross Profit | $174K | $410K | $457K | $216K | $76K |
| Gross Margin | 36.1% | 43.0% | 42.6% | 40.3% | 19.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $6K |
| SG&A Expenses | $273K | $334K | $1M | $638K | $377K |
| Operating Expenses | $738K | $746K | $1M | $638K | $382K |
| Operating Income | -$564K | -$336K | -$562K | -$422K | -$307K |
| Operating Margin | -117.4% | -35.2% | -52.4% | -78.9% | -79.8% |
| Interest Expense | $18K | $3K | $0 | $0 | $9K |
| Income Before Tax | -$581K | -$339K | -$562K | -$422K | -$316K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$581K | -$339K | -$562K | -$422K | -$316K |
| Net Margin | -121.0% | -35.5% | -52.4% | -78.9% | -82.3% |
| EPS (Diluted) | $-0.05 | $-0.03 | $-0.05 | $-0.03 | $-0.03 |
| EBITDA | -$564K | -$336K | -$562K | -$422K | -$305K |
| Shares Outstanding | 11M | 13M | 14M | 17M | 17M |